430 participants
Study of Ibrutinib vs Placebo, in Combination With Nab-paclitaxel and Gemcitabine, in the First Line Treatment of Patients With Metastatic Pancreatic Adenocarcinoma (RESOLVE)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-12-30
- Start Date:
- 2015-05-31
- Completion:
- 2018-10-31
Conditions
- Metastatic Pancreatic Adenocarcinoma
Interventions
- DRUG